Expression and Clinicopathological Significance of S100 Calcium Binding Protein A2 in Lung Cancer Patients of Chinese Han Ethnicity.

Ting Wang,Yiqian Liang,Asmitananda Thakur,Shuo Zhang,Feng Liu,Hamadhaider Khan,Puyu Shi,Ning Wang,Mingwei Chen,Hui Ren

DOI: https://doi.org/10.1016/j.cca.2016.11.027

IF: 6.314

2016-01-01

Clinica Chimica Acta

Abstract:Background: 5100 family of calcium-binding proteins plays a significant role in the process of many kinds of tumors, including lung cancer. As an important member of this family, S100 calcium binding protein A2 (S100A2) has been confirmed to be associated with many biological processes, and has an abnormal expression in non-small cell lung cancer (NSCLC). However, the S100A2 status in lung cancer is still controversial and undefined.Methods: We evaluated the pattern and distribution of S100A2 in 109 cases of lung cancer, including five histological types (47 adenocarcinoma, 46 squamous cell carcinoma, 7 small cell carcinoma, 3 large cell carcinoma, and 6 atypical carcinoid), and 30 cases of paired adjacent normal lung tissues by means of immunohistochemistry.Results: Compared with the normal tissues (0/30), S100A2 experienced a dramatically upward trend of positive expression in lung cancer, with a positive rate of 68/109 (P < 0.001). Specifically, squamous cell carcinoma, with 34/12, had the highest expression ratio, followed by large cell carcinoma (2/1), adenocarcinoma (31/16), and atypical carcinoid (1/5) respectively, while no S100A2 protein was detected in small cell carcinoma. Meanwhile, we firstly demonstrated that the high expression of S100A2 was significantly associated with the incidence of lymph node metastasis in adenocarcinoma (P = 0.013).Conclusions: The association between high S100A2 expression and NSCLC at the level of tissue, and S100A2 may serve as an effective biomarker for the diagnosis and prognosis of NSCLC in future. (C) 2016 Published by Elsevier B.V.